Precision psychiatry as a clinical discipline is the integration of multiple variables — clinical phenotype, biomarkers, genetic factors, prior treatment response, comorbidities, patient preferences, access realities, life context — to match treatment to individual patient rather than to diagnostic category. The frame applies across psychiatric conditions and across treatment modalities; the discipline produces measurably better outcomes than generic diagnosis-based care when consistently practiced.
The variables in precision matching. Clinical phenotype within diagnostic category (Stage 23.3) — depression subtype, anxiety subtype, etc. Biomarker findings (Stage 23.2) — hs-CRP, thyroid panel, metabolic markers, others. Genetic factors (Stage 23.1) — CYP variants, others when relevant. Prior treatment response — what has worked, what has failed, what was inadequately tried. Comorbidities — psychiatric and medical conditions that interact with treatment selection. Patient preferences — autonomy in choosing among reasonable options. Access realities — what is available, affordable, sustainable. Life context — career, family, structural factors that shape treatment feasibility.
The practice of integrated decision-making. Detailed initial workup that characterizes the variables. Treatment selection that integrates the variables rather than defaulting to first-line by category. Reassessment based on response with attention to which variables predicted accurate matching. Refinement of subsequent treatment based on integrated picture. The practice is more time-intensive than generic prescribing but produces measurably better outcomes — fewer failed trials, faster response, better long-term adherence.
The longitudinal data integration. The patient's clinical record across years contains the precision information — what subtypes, biomarkers, prior responses, contextual factors apply to them specifically. The continuing clinical relationship across years (Stage 28.1) supports precision practice; the practitioner who knows the patient deeply integrates the variables effectively. The episodic care relationship cannot replicate the depth of integrated decision-making across decades.
The realistic limits of precision psychiatry. Some treatment selection remains based on patient preference and trial-and-error within reasonable options. Not all variables have established predictive value. The promise of pharmacogenomics, biomarker prediction, and AI-driven treatment selection has often exceeded delivery. The current practice integrates what evidence supports while acknowledging the limits. Over the next decade, the precision approach is likely to mature substantially with advances in biomarkers, imaging, and treatment-prediction tools; the foundation of careful clinical practice remains essential. The discipline is to engage precision psychiatry as integrated multi-variable clinical practice, collect the relevant data systematically, integrate across variables in treatment decisions, and build the longitudinal relationships that support deep individual understanding.